- 专利标题: Glucagon-GLP-1-GIP triple agonist compounds
-
申请号: US16151603申请日: 2018-10-04
-
公开(公告)号: US11111285B2公开(公告)日: 2021-09-07
- 发明人: Rasmus Just , Ditte Riber , Anne Pernille Tofteng Shelton , Torben Østerlund , Kate Hansen , Lene Jessen
- 申请人: Zealand Pharma A/S
- 申请人地址: DK Glostrup
- 专利权人: Zealand Pharma A/S
- 当前专利权人: Zealand Pharma A/S
- 当前专利权人地址: DK Glostrup
- 代理机构: Clark & Elbing LLP
- 主分类号: C07K14/605
- IPC分类号: C07K14/605 ; A61K38/00 ; A61P19/08 ; A61P19/10 ; A61P29/00 ; A61P3/00 ; A61P3/04 ; A61P3/06 ; A61P3/10
摘要:
The present invention relates to compounds which have agonist activity at the glucagon, GIP and GLP-1 receptors, and to their use in the treatment of metabolic disorders.
公开/授权文献
- US20190270789A1 GLUCAGON-GLP-1-GIP TRIPLE AGONIST COMPOUNDS 公开/授权日:2019-09-05